We have developed an innovative strategy to deliver in a broad range of organs the IL-7 cytokine with the goal to restore both innate and adaptive immunity of immunosuppressed patients with bacterial sepsis and COVID-19. Here, IL7 is linked to bacterial infectious disease with sepsis.